Mehdi Hatami, Khalil Farhadi, Amir Tukmechi
Index: Chirality 24(8) , 634-9, (2012)
Full Text: HTML
The applicability of two-phase liquid-phase micro-extraction (LPME) in porous hollow polypropylene fiber for the sample preparation and the stereoselective pharmacokinetics of mebeverine (MEB) enantiomers (an antispasmodic drug) in rat after intramuscular administration were studied. Plasma was assayed for MEB enantiomer concentrations using stereospecific high-performance liquid chromatography with ultraviolet detection after a simple, inexpensive, and efficient preconcentration and clean-up hollow fiber-based LPME. Under optimized micro-extraction conditions, MEB enantiomers were extracted with 25 µl of 1-octanol within a lumen of a hollow fiber from 0.5 ml of plasma previously diluted with 4.5 ml alkalized water (pH 10). The chromatographic analysis was carried out through chiral liquid chromatography using a DELTA S column and hexane-isopropyl alcohol (85:15 v/v) containing 0.2% triethylamine as mobile phase. The mean recoveries of (+)-MEB and (-)-MEB were 75.5% and 71.0%, respectively. The limit of detection (LOD) was 3.0 ng/ml with linear response over the concentration range of 10-2500 ng/ml with correlation coefficient higher than 0.993 for both enantiomers. The pharmacokinetic studies showed that the mean plasma levels of (+)-MEB were higher than those of (-)-MEB at almost all time points. Also, (+)-MEB exhibited greater t(max) (peak time in concentration-time profile), C(max) (peak concentration in concentration-time profile), t(1/2) (elimination half-life), and AUC(0-240 min) (area under the curve for concentration versus time) and smaller CL (clearance) and V(d) (apparent distribution volume) than its antipode. The obtained results implied that the absorption, distribution, and elimination of (-)-MEB were more rapid than those of (+)-MEB and there were stereoselective differences in pharmacokinetics.Copyright © 2012 Wiley Periodicals, Inc.
Structure | Name/CAS No. | Molecular Formula | Articles |
---|---|---|---|
![]() |
Mebeverine hydrochloride
CAS:2753-45-9 |
C25H36ClNO5 |
Validated chromatographic and spectrophotometric methods for...
2013-01-01 [Pak. J. Pharm. Sci. 26(1) , 175-83, (2013)] |
Preparation and in vitro evaluation of mebeverine HCl colon-...
2011-08-01 [Pharm. Dev. Technol. 16(4) , 331-42, (2011)] |
Quantitative HPLC analysis of mebeverine, mesalazine, sulpha...
2011-03-25 [J. Pharm. Biomed. Anal. 54(4) , 646-52, (2011)] |
A systematic review of efficacy and tolerability of mebeveri...
2010-02-07 [World J. Gastroenterol. 16(5) , 547-53, (2010)] |
Validated HPLC determination of the two fixed dose combinati...
2010-01-01 [J. AOAC Int. 93(4) , 1192-200, (2010)] |
Home | MSDS/SDS Database Search | Journals | Product Classification | Biologically Active Compounds | Selling Leads | About Us | Disclaimer
Copyright © 2024 ChemSrc All Rights Reserved